558-11713-17870
3 vaccinations
6 coded responses
21 check-ins
6 free-text entries
11 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 960 / CA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2020-12-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-22
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-26
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-27
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-28
Health check-in — day 7, dose 1Feeling: Good · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-28
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-04
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-15
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-18
Health check-in — day 7, dose 2Feeling: Fair · Site: Pain, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-18
Report sent to call center — day 7, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-23
Survey response — day 14, dose 2MedDRA: Arthralgia, Myalgia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Joint pain and muscle pain, specifically to arms and knees. On a scale of 1 to 10, 10 being worst pain, I would rate my pain level as 6/10.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-08
Survey response — day 28, dose 2MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Increased tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-13
Survey response — day 35, dose 2MedDRA: Pre-existing disease — Feeling: Good · Be unable to do your normal daily activitiesFree text: DepressionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Survey response — day 42, dose 2MedDRA: Headache, Pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache and body painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-10
-
2021-07-10
Survey response — 6 months, dose 2MedDRA: COVID-19, Cough, Dyspnoea, Fatigue, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, cough, shortness of breath, congestion, fatigue, covid positiveMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-11-03
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-01-09
- 2022-05-06
-
2022-11-05
Survey response — 12 months, dose 3MedDRA: Pain, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Congestion, body achesMedDRA releases: 2024-11 · check-in free text available
-
2022-11-05
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-11-03 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-22 | priority 2/3 | |
| 2020-12-26 | priority 2/3 | |
| 2020-12-27 | priority 2/3 | |
| 2020-12-28 | priority 2/3 | |
| 2021-01-10 | priority 2/3 | |
| 2021-01-11 | priority 2/3 | |
| 2021-01-12 | priority 2/3 | |
| 2021-01-14 | priority 2/3 | |
| 2021-01-15 | priority 2/3 | |
| 2021-01-18 | priority 2/3 | |
| 2022-11-05 | Unsuccessful |
Free text
Release 2 — day 14, dose 2
Symptoms: Joint pain and muscle pain, specifically to arms and knees. On a scale of 1 to 10, 10 being worst pain, I would rate my pain level as 6/10.
Release 3 — day 28, dose 2
Symptoms: Increased tiredness
Release 4 — day 35, dose 2
Symptoms: Depression
Release 4 — day 42, dose 2
Symptoms: Headache and body pain
Release 9 — 6 months, dose 2
Symptoms: Fever, cough, shortness of breath, congestion, fatigue, covid positive
Release 12 — 12 months, dose 3
Symptoms: Congestion, body aches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release